Otonomy Investor Relations Material
Latest events
Q2 2022
Otonomy
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Otonomy Inc
Access all reports
Otonomy Inc. is a biopharmaceutical company focused on the development of therapeutics for the treatment of ear-related disorders. The company leverages proprietary drug delivery technology to create sustained-exposure formulations designed for conditions such as hearing loss, tinnitus, and otitis media. Otonomy’s pipeline includes both investigational therapies and products aimed at addressing unmet medical needs in otology. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
OTIC
Country
🇺🇸 United States